|Sir Bruce Keogh
|National Medical Director|
1 April 2013
|Preceded by||No previous incumbents|
|NHS Medical Director (England)|
12 November 2007 – 31 March 2013
|Preceded by||No previous incumbents|
|Succeeded by||No successor. Post transferred to NHS England in April 2013.|
24 November 1954 |
Salisbury, Southern Rhodesia (Now Harare, Zimbabwe)
|Alma mater||Charing Cross Hospital Medical School
|Occupation||National Medical Director, England|
|Profession||Physician and Surgeon|
Sir Bruce Edward Keogh, KBE, FRCS, FRCP, (born 24 November 1954) has been Medical Director of the National Health Service in England since 2007 and National Medical Director of the NHS Commissioning Board (NHS England) since 2013.
Keogh was born on 24 November 1954 in Harare, Zimbabwe (formerly Rhodesia), the son of Gerald and Marjorie Beatrice Keogh (née Craig). He attended the private Catholic boys school St George's College, Harare.
He was a demonstrator in anatomy at Charing Cross Hospital Medical School before training in general surgery in London and Sheffield and gaining his FRCS in 1985. He then opted for a career in cardiac surgery, returning to the Hammersmith Hospital as a registrar. During this time he spent a year as a laboratory based British Heart Foundation Junior Research Fellow which led to the award of the MD higher degree in 1989 for research into laser coronary angioplasty. He was appointed as senior registrar on the West London training rotation where he spent time at St George's Hospital and the Harefield Hospital training in cardiac, pulmonary and oesophageal surgery. He was subsequently appointed a university Senior Lecturer in cardiothoracic surgery at the Royal Postgraduate Medical School and honorary consultant surgeon at the Hammersmith Hospital between 1991-1995. He then took an NHS consultant position in Birmingham where he became the clinical service lead for cardoithoracic surgery and Associate Medical Director for Clinical Governance at University Hospital Birmingham before being appointed Professor of cardiac surgery at University College London and Director of Surgery at The Heart Hospital in 2004.
In 1994 he established the National Adult Cardiac Surgical Database and as a consequence he is perhaps best known for his work promoting the measurement, analysis and public disclosure of clinical outcomes. But he has also published numerous peer reviewed scientific articles on coronary artery vasomotor tone, the effect of cardiopulmonary bypass on gut blood flow and function, myocardial protection during surgery, surgery for patients with poor left ventricular function and the effects of social deprivation on cardiac surgical outcomes. He has co-authored a book on the Evidence for Cardiothoracic Surgery (2005) and another on Normal Surface Anatomy (1984). While at UCL he brought the national registries on adult and paediatric cardiac surgery, myocardial infarction, coronary angioplasty and pacemakers into a new National Institute for Cardiovascular Outcomes Research.
Keogh has been active on many medical and professional committees. He has been secretary and president of the Society for Cardiothoracic Surgery in Great Britain and Ireland, Secretary General of the European Association for Cardio-Thoracic Surgery and president of the Cardiothoracic Section of the Royal Society of Medicine and served on the Council of the Royal College of Surgeons of England and the Board of Directors of the Society of Thoracic Surgeons in the US. He is an elected member of the American Association for Thoracic Surgery and a Fellow of the European Society of Cardiology.
Prior to becoming Medical Director of the National Health Service he served on the National Coronary Heart Disease Taskforce, the NHS Standing Medical Advisory Committee, and was chairman of the NHS Information Taskforce on Clinical Outcomes for the Department of Health. He has also served as Commissioner on the Commission for Health Improvement and the Healthcare Commission.
NHS Medical Director
As Medical Director of the NHS (2007–13) he was a Director General in the Department of Health where he led the Medical Directorate which had oversight for clinical policy and strategy in the NHS. This included the more specific work of the National Clinical Directors and their associated strategies such as those for coronary heart disease, stroke, cancer, respiratory disease, renal disease, liver disease, trauma and transplantation. He established the Healthcare Quality Improvement Partnership (HQIP)a joint venture between the Academy of Medical Royal Colleges and the Royal College of Nursing to develop and run the national clinical audits.
Keogh's role also included oversight of the medicines supply chain into the UK, policy relating to the pharmaceutical industry, drug pricing, prescriptions and the role of pharmacy in England and sponsorship of the work programmes of the National Institute for Health and Clinical Excellence (NICE) and the National Patient Safety Agency (NPSA), including the National Confidential Enquiries and the National Research Ethics Service. Through sponsorship of Medical Education England he had oversight of postgraduate education of doctors, dentists, pharmacists and clinical scientists.
In 2008 he established and co-chaired The Organ Donation Taskforce Programme Delivery Board which has led to a 50% increase in the number of organ donors for transplantation over the following five years.
In 2009 he led a national taskforce to improve neonatal services.
Keogh's team was responsible for implementing the majority of the recommendations from Lord Darzi's review of the NHS "High Quality Care for All" published in 2008. This review has been credited with refocusing the NHS on quality of care. Keogh's team also developed the Quality Framework for the NHS (based on the work of Sheila Leatherman)and included in Darzi's review. The principles were simple: Define what is meant by quality, measure it, publish it for everyone to see, reward those who do well, regulate for minimum standards, promote and develop leadership for quality within the NHS and promote research and innovation within the NHS, by drawing on and linking with the best British universities and biotechnology companies in to form academic science networks. The resultant definition of healthcare quality based on the provision of effective care, safe care and a positive experience became widely accepted and was subsequently enshrined in the Health and Social Care Act (2012).
Following the election of a coalition Government in 2010 he was tasked with making clinical outcomes the currency of NHS business. In response his team developed the NHS Outcomes Framework which was based on the observation that all healthcare systems should do five things well: Firstly, the NHS should stop you dying prematurely from things they could influence through treatment or prevention through immunisations eg stroke, heart attacks, measles. Secondly, the NHS should look after you well if you have a long term medical condition such as diabetes, asthma, arthritis. Thirdly, the NHS should treat you effectively if you need a short episode of care e.g. broken leg, an operation of infection. Fourthly, the NHS should treat you well. The experience should be as positive as possible, ranging from participation in decisions about your treatment to decent customer service. Finally, the NHS should treat you safely. All of these are measurable at different levels. They also dovetail with the definition of quality in the three domains of effectiveness, safety and experience.
Following the Lansley reforms of the NHS he was appointed National Medical Director in NHS England from 2013, where he is responsible for promoting a focus on quality, clinical leadership and innovation. To facilitate these aims he was responsible for overseeing the establishment of Academic Health Science Networks, Strategic Clinical Networks and Clinical Senates.
The five domains of the NHS Outcomes Framework have formed the basis of NHS England's planning guidance for the NHS where they give clarity of purpose and direction to the NHS in a way that was previously undefined.
With the advent of medical revalidation he became the senior responsible officer in England.
Keogh has published several significant national reviews.
In 2012 he co-chaired a review of medical and dental school intakes on behalf of the Higher Education Funding Council and the Department of Health.
In 2012 he was asked by the Secretary of State for Health to investigate the safety of PIP breast implants, a product of fraudulent quality, but concluded that although they were more likely to rupture than other implants they did not pose significant health risk to women a finding endorsed by a subsequent European report  in 2013
In 2013 he published three significant reports - One on how to improve safety in the cosmetic intervention industry through a review of regulation, a second, widely known as the Keogh Review on the 14 Trusts with the highest mortality rates in England. and a third presenting a vision for the future of urgent and emergency care services in England.
He is currently leading a forum on how to move the NHS towards greater 7 day services. Initial recommendations were approved by the NHS England Board in December 2013.
In 2012 Keogh was asked by Jeremy Hunt the Secretary of State for Health to reassure him that there had been adequate clinical consultation on proposals to recofigure services in south London. In a letter to the Secretary of State he concluded that there had been adequate clinical consultation, but he also included a thinly veiled warning about closing Lewisham A&E. His advice was seen by some as an intervention to protect and prevent the closure of Lewisham A&E and by others as the opposite. Much debate centred around a projection regarding the number of lives that might be saved, a calculation of unknown origin - attributed by some to Keogh and by others to work conducted by the London Clinical Senate.
In 2013 Keogh provoked the suspension of children's heart surgery in Leeds just before the Easter weekend, based on evidence from Professor Sir Roger Boyle, the former national heart czar and Director of the National Institute for Cardiovascular Outcomes Research, that the mortality rate was 2.75 times higher than might be expected for their practice. Keogh was also concerned that one consultant surgeon was suspended from operating, that the senior consultant was on holiday and that the remaining surgeons were locums. The hospital could not contradict the mortality figures, so he suggested suspending surgery till the full facts could be verified. It subsequently turned out that Leeds had submitted poor data (20 times more missing data than any other unit in the country) to the national registry. After Leeds had submitted accurate and complete data, reanalysis showed that although they still had the highest mortality in the country they were within normal statistical boundaries. His intervention was widely regarded as sensible and pre-emptory given the evidence, but some thought it precipitous. Keogh remained unrepentant, arguing he would rather be remembered for preventing an avoidable disaster than responsible for not acting on reasonable doubt. He cited examples of prevarication at Bristol in the 1990s and Mid Stafforshire in the 2000s when some people argued over data while other people were harmed.
Keogh was appointed as an honorary Knight Commander of the Order of the British Empire (KBE) in 2003. He subsequently became a British citizen, and as part of the Queen's Birthday Honours on 11 June 2005, his knighthood became substantive (back dated to 5 February 2004).
Keogh is an honorary Fellow of the Royal College of Physicians of London, the Royal College of General Practitioners, the Royal College of Anaesthetists, the Royal College of Surgeons in Ireland, the American College of Surgeons and the British Society of Interventional Radiology. He has been a visiting professor at universities in Japan, China and North America. Closer to home he has been King James IV Professor  of the Royal College of Surgeons of Edinburgh (2005) and Tudor Edwards lecturer (2007), and Hunterian Orator (2013) for the Royal College of Surgeons of England and Kinmonth Lecturer (2013) jointly for the Royal College of Surgeons of England and the Vascular Society of Great Britain and Ireland.
He holds honorary medical doctorates from the universities of Birmingham and Sheffield and Doctorates of Science from the University of Toledo and Coventry University. He is a member of the Lunar Society, on the council of the British Heart Foundation and a vice patron of the Royal British Legion Poppy Factory. He was a judge for the inaugural 2010 Hippocrates Prize for Poetry and Medicine.
During 2013 he was said by the Health Service Journal to be the most influential clinician and the sixth most powerful person in the English NHS. In 2014 he was included in the Sunday Times and Debretts list of Britain's 500 most influential people.
Keogh has been married to his wife, Ann, since they met at medical school. The couple have four sons, whose names are, in descending order of age, Robert, Christopher, William and Michael.
- "Prof Sir Bruce Keogh, KBE". People of Today. Debrett's. Retrieved 15 August 2012.
- "KEOGH, Prof. Sir Bruce (Edward)". Who's Who 2012. A & C Black. 2011.
- European Association for Cardio-Thoracic Surgery website
- Society of Thoracic Surgeons website
- The London Gazette: . 11 June 2005. Retrieved 2012-08-15.
- List of King James IV Professors
- The Poppy Factory website
- "HSJ100 2013 The annual list of the most influential people in health". Health Service Journal. 11 December 2013. Retrieved 14 December 2013.